Efficacy and Safety of 5% Minoxidil Topical Foam in Male Pattern Hair Loss Treatment and Patient Satisfaction

Efficacy and Safety of 5% Minoxidil Topical Foam in Male Pattern Hair Loss Treatment and Patient Satisfaction Publisher Pubmed

Hasanzadeh H¹ ; Nasrollahi SA¹ ; Halavati N² ; Saberi M³ ; Firooz A^{1, 2}

Show Affiliations

1. Pharmaceutical, Cosmeceutical, and Hygienic Skin Products Clinical Evaluation Lab (DermaLab), Center for Research and Training in Skin Diseases & Leprosy (CRTSDL), Tehran University of Medical Sciences (TUMS), Tehran, Iran
2. Clinical Trial Center (CTC), Tehran University of Medical Sciences (TUMS), Tehran, Iran
3. Community-Based Participatory Research Center, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences (TUMS), Tehran, Iran

Source: Acta Dermatovenerologica Alpina# Pannonica et Adriatica Published:2016

Abstract

Introduction: Male pattern hair loss is widespread around the world. Its prevalence indicates the importance of finding the best treatment modalities. This study evaluates the efficacy and safety of minoxidil 5% topical foam in male pattern hair loss treatment and patient satisfaction. Methods: This study was a before-and-after trial on 17 male patients with male pattern hair loss. Subjects were instructed to apply one capful (1 ml) of minoxidil 5% topical foam on the scalp daily for 6 months. Efficacy was assessed through hair counts, subject assessment, and global photographic review. Results: Seventeen male volunteers were recruited, and three volunteers were withdrawn; 14 participated in the trial for 16 weeks, and 12 continued up to 24 weeks. The average hair count with a camera at week 16 (181.87 ± 52.42) and week 24 (194.58 ± 62.82) and with an eye count at week 16 (62.57 ± 15.28) and week 24 (69.91 ± 15.61) increased significantly compared to the baseline after intervention. Conclusion: This study confirmed that minoxidil 5% topical foam is a safe and effective treatment for MPHL. The effect of it is evident after 24 weeks of use. © 2016, Slovenian Medical Society. All rights reserved.

Style	Citing Format
MLA	Hasanzadeh H, et al.. "Efficacy and Safety of 5% Minoxidil Topical Foam in Male Pattern Hair Loss Treatment and Patient Satisfaction." Acta Dermatovenerologica Alpina# Pannonica et Adriatica, vol. 25, no. 3, 2016, pp. 41-44.
APA	Hasanzadeh H, Nasrollahi SA, Halavati N, Saberi M, Firooz A (2016). Efficacy and Safety of 5% Minoxidil Topical Foam in Male Pattern Hair Loss Treatment and Patient Satisfaction. Acta Dermatovenerologica Alpina# Pannonica et Adriatica, 25(3), 41-44.
Chicago	Hasanzadeh H, Nasrollahi SA, Halavati N, Saberi M, Firooz A. "Efficacy and Safety of 5% Minoxidil Topical Foam in Male Pattern Hair Loss Treatment and Patient Satisfaction." Acta Dermatovenerologica Alpina# Pannonica et Adriatica 25, no. 3 (2016): 41-44.
Harvard	Hasanzadeh H et al. (2016) 'Efficacy and Safety of 5% Minoxidil Topical Foam in Male Pattern Hair Loss Treatment and Patient Satisfaction', Acta Dermatovenerologica Alpina# Pannonica et Adriatica, 25(3), pp. 41-44.
Vancouver	Hasanzadeh H, Nasrollahi SA, Halavati N, Saberi M, Firooz A. Efficacy and Safety of 5% Minoxidil Topical Foam in Male Pattern Hair Loss Treatment and Patient Satisfaction. Acta Dermatovenerologica Alpina# Pannonica et Adriatica. 2016;25(3):41-44.
BibTex	@article{ author = {Hasanzadeh H and Nasrollahi SA and Halavati N and Saberi M and Firooz A}, title = {Efficacy and Safety of 5% Minoxidil Topical Foam in Male Pattern Hair Loss Treatment and Patient Satisfaction}, journal = {Acta Dermatovenerologica Alpina# Pannonica et Adriatica}, volume = {25}, number = {3}, pages = {41-44}, year = {2016} }
RIS	TY - JOUR AU - Hasanzadeh H AU - Nasrollahi SA AU - Halavati N AU - Saberi M AU - Firooz A TI - Efficacy and Safety of 5% Minoxidil Topical Foam in Male Pattern Hair Loss Treatment and Patient Satisfaction JO - Acta Dermatovenerologica Alpina# Pannonica et Adriatica VL - 25 IS - 3 SP - 41 EP - 44 PY - 2016 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract